Tesamorelin 20mg + Ipamorelin + CJC 5mg each (All-in-One Blend!!)

This combination includes three peptides—Tesamorelin, Ipamorelin, and CJC-1295 (without DAC)—each contributing to the stimulation of growth hormone (GH) release through different mechanisms. Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), CJC-1295 is a modified GHRH analogue, and Ipamorelin is a selective ghrelin receptor agonist. Together, they work synergistically to enhance GH secretion and its associated benefits.

CJC-1295 (No DAC and DAC)

Also known as Modified GRF (1-29), CJC-1295 is a synthetic peptide composed of 29 amino acids and is an analogue of growth hormone-releasing hormone (GHRH). It closely resembles natural GHRH, differing by only four amino acid substitutions, but it remains active in the bloodstream for a significantly longer duration. Clinical studies have demonstrated that CJC-1295 effectively increases growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels in humans without serious adverse effects. A 2001 study showed that a 14-day subcutaneous regimen of CJC-1295 was safe and well tolerated.

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue and a ghrelin receptor agonist. It stimulates growth hormone release with potency comparable to other GHRPs but with fewer appetite-stimulating effects. Unlike many other GH secretagogues, ipamorelin does not significantly increase the secretion of cortisol, acetylcholine, prolactin, or aldosterone, making it the first selective GH secretagogue with this profile.

Tesamorelin

Tesamorelin is a growth hormone-releasing hormone analogue that raises IGF-1 levels in both men and women by an average of 181 micrograms per liter. It binds and activates human GHRH receptors with potency similar to endogenous GHRH. Besides stimulating growth hormone release, tesamorelin offers additional benefits such as nootropic effects and triglyceride reduction. Recent studies show that it decreases carotid intima-media thickness (CIMT), visceral adipose tissue (VAT), and C-reactive protein (CRP) levels. It does not significantly affect other pituitary hormones. Furthermore, tesamorelin has been shown to improve cognitive function in healthy older adults as well as in individuals with mild cognitive impairment at risk for progressing to Alzheimer’s disease.

Research Applications

The Tesamorelin 20mg + Ipamorelin + CJC-1295 5mg blend is primarily utilized in scientific studies focusing on:

• Fat Reduction: Investigating its potential to reduce visceral fat accumulation.
• Muscle Growth: Exploring its effects on increasing lean muscle mass.
• Cognitive Function: Assessing its impact on memory and cognitive performance.
• Sleep Quality: Studying its role in improving sleep patterns and quality.
• Energy Levels: Evaluating its effects on overall energy and vitality.

These applications are part of ongoing research aimed at understanding the broader implications of this peptide blend in various biological processes.

Product Specifications

• Form: Lyophilized (freeze-dried) powder for reconstitution.
• Purity: 99% or higher, ensuring high-quality material for research purposes.
• Packaging: Each package contains 1 vial, each with 30 milligrams of the peptide blend (20mg Tesamorelin, 5mg Ipamorelin, 5mg CJC-1295).

This product is intended strictly for laboratory research and is not approved for human consumption.

Referenced Citations:

• Teichman, S. L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J. P., & Frohman, L. A. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor 1 secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism, 91(3), 799–805. 
• Sackmann-Sala, L., Ding, J., Frohman, L. A., & Kopchick, J. J. (2009). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Hormone & IGF Research, 19(6). 
• Onescu, M., & Frohman, L. A. (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology & Metabolism, 91(12), 4792–4797.